Core One Labs Inc C.COOL

Core One Labs’ Akome Receives Positive Results

[Betteryear2]

VANCOUVER, British Columbia, April 02, 2022 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”) is pleased to announce that its wholly owned subsidiary Akome Biotech Ltd. (“Akome”) through a research arrangement with Neuro-Zone Srl, (“Neuro-Zone”) based in Bresso, Italy, has achieved positive results from its in vitro biological assay (“bioassay”) development studies (“bioassay studies”); furthering the Company’s patent pending psychedelic bioactive compounds that could lead to groundbreaking drug formulations for Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Major Depressive Disorder (Depression) and Stroke, (collectively “targeted diseases” or “neurological indications”).
 

Core One Labs’ Akome Receives Positive Results from Bioassay Studies

 

 

[bullman246]

This company and its management team of scam artists, are a complete loser! No one wants this compny, not even the management, who own little shares. If this company had any real potential, large money interests, would have taken a large position, long ago. With no revenue for the foreseeable future (probably years away), burning through millions of dollars, any wonder this POS company is being